Literature DB >> 14744171

Single-dose intravenous valproate in acute mania.

Katrina Phrolov1, Julia Applebaum, Joseph Levine, Hanoch Miodovnick, R H Belmaker.   

Abstract

OBJECTIVE: High-dose loading with oral and intravenous valproate has been reported to be therapeutic in mania over 48 to 72 hours. We hypothesized that very high dose intravenous (IV) valproate might have even more rapid effects equivalent to effects in status epilepticus that occur within 20 minutes.
METHOD: Seven patients with mania (Young Mania Rating Scale score > 20) and minimal prior drug treatment were given valproate 20 mg/kg IV over 30 minutes.
RESULTS: No antimanic effects were observed during 120 minutes of observation. There were no side effects.
CONCLUSION: Slowly evolving biochemical changes, perhaps at the gene level, may be required for the antimanic effect of anticonvulsants.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744171     DOI: 10.4088/jcp.v65n0111

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  3 in total

1.  Evidence for involvement of ERK, PI3K, and RSK in induction of Bcl-2 by valproate.

Authors:  Thomas K Creson; Peixiong Yuan; Husseini K Manji; Guang Chen
Journal:  J Mol Neurosci       Date:  2008-08-03       Impact factor: 3.444

2.  Neuronal peroxisome proliferator-activated receptor gamma signaling: regulation by mood-stabilizer valproate.

Authors:  Martin J Lan; Peixiong Yuan; Guang Chen; Husseini K Manji
Journal:  J Mol Neurosci       Date:  2008-04-25       Impact factor: 3.444

Review 3.  Separate and concomitant use of lamotrigine, lithium, and divalproex in bipolar disorders.

Authors:  Daniel Z Lieberman; Frederick K Goodwin
Journal:  Curr Psychiatry Rep       Date:  2004-12       Impact factor: 8.081

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.